ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Monitoring Brain Activity in Human Brain Injury

This study is not yet open for participant recruitment.
Verified by Soroka University Medical Center, October 2005

Sponsored by: Soroka University Medical Center
Information provided by: Soroka University Medical Center
ClinicalTrials.gov Identifier: NCT00258505
  Purpose

The outcome of brain injury (physical or stroke) may be related to a brain electrical phenomenon known as Cortical Spreading Depression (CSD). This is a brief cessation of function in a local region of brain tissue. It has been hypothesized that CSD may occur after brain injury and may expand the damage to adjacent brain areas. Our aim is to detect CSD by means of intracranial electrodes in patients with brain injuries and asses how these events alter the outcome of the patients.


Condition Intervention
Traumatic Brain Injury
Aneurysmal Subarachnoid Hemorrhage
Cerebral Infarction
Cerebral Hemorrhage
Procedure: Procedure: intracranial monitoring up to 9 days after injury

MedlinePlus related topics:   Depression    Head and Brain Injuries    Injuries    Wounds   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Natural History, Longitudinal, Defined Population, Prospective Study
Official Title:   Incidence, Nature and Consequences of Cortical Depolarizations in Human Brain Injury From Trauma and Ischemia: The COSBID Study

Further study details as provided by Soroka University Medical Center:

Estimated Enrollment:   100
Estimated Study Completion Date:   September 2007

Detailed Description:

Cortical spreading depression (CSD) is a wave of mass neuronal firing and neuronal and glial depolarisation which propagates through grey matter in the central nervous system in response to a pathologic stimulus, at a rate of between 1 and 5 mm per minute. First described by Leão in 1944 as a sudden depression of ECoG amplitude spreading across the cortex of the rabbit (Leao, A. A. P. 1944), CSD can be elicited in experimental animals by chemical, electrical, and mechanical stimuli, with varying degrees of ease. CSD provoked in healthy, normally perfused neural tissue does not induce persistent metabolic stress or cellular damage, and indeed such induction of CSD in animal experiments may confer protection against the adverse effects of a subsequent ischaemic insult (Kobayashi, S. et al. 1995).

In animal models of focal cerebral ischaemia, usually induced by occlusion of the middle cerebral artery, a spontaneous phenomenon occurs around the periphery of the core territory, with electrophysiological features essentially identical with CSD, and similar capacity to propagate across cerebral cortex. Designated "peri-infarct depolarisation" (PID), this event is associated with infarct expansion, or recruitment of at-risk cortical territory into the expanding core, and has been shown capable of causing this expansion, in the absence of therapeutic intervention. Indeed it has been hypothesized that glutamate release may be involved in PID generation, and that excitotoxicity may accomplish detrimental effects via this route (Hossmann, K. A. 1994), (Obrenovitch, T. P. and Urenjak, J. 1997). Some experimental neuroprotection treatments for stroke act to decrease the incidence of PID (Iijima, T. et al. 1992;Chen, Q. et al. 1993;Busch, E. et al. 1996).

In traumatic and ischaemic (especially in middle cerebral artery occlusion and aneurysmal subarachnoid haemorrhage) brain injury in humans, a phase of delayed deterioration often associated with severe and refractory brain swelling develops between 2 and 5 days after the initial ictus, and is associated with poor or fatal outcome. The cause and mechanism of this deterioration remain poorly understood, and the possibility exists that CSD/PID events might contribute to deterioration.

To date, CSD or PID have been reported in only ten human subjects in two papers (Mayevsky, A. et al. 1996; Strong, A. J. et al. 2002). Strong et al. reported that transient ECoG suppressions suggestive of depolarisations are common - but by no means universal - after brain injury in humans. Sub-dural ECoG electrode strips were placed in 14 patients who had undergone craniotomy for trauma or intracranial hemorrhage; monitoring was for up to 60 h following the injury. Five of these patients (36%) showed patterns of ECoG depression consistent with PID/CSD in brain regions adjacent to the primary injury.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

Immediately following:

  • traumatic brain injury
  • aneurysmal subarachnoid haemorrhage or
  • spontaneous intracerebral haematoma or
  • stroke involving cerebral cortex

Exclusion Criteria:

  • GCS = 3
  • Bilateral fixed & dilated pupils or other evidence of massive irreversible brain injury
  • more than 5 days post Injury/ictus.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00258505

Contacts
Contact: Anthony Strong, Prof.     Anthony.strong@kcl.ac.uk    

Locations
Germany
Charite     Recruiting
      Berlin, Germany
      Contact: Jens Dreier, MD         jens.dreier@charite.de    
      Principal Investigator: Jens Dreier, MD            
Israel
Soroka     Not yet recruiting
      Beer-Sheva, Israel, 84101
      Contact: Alon Friedman, MD/PhD         alonf@bgu.ac.il    
      Principal Investigator: Alon Friedman, MD/PhD            

Sponsors and Collaborators
Soroka University Medical Center

Investigators
Principal Investigator:     Alon Friedman, MD/PhD     Soroka University Medical Center    
Principal Investigator:     Jens Dreier, MD     Charite, Berlin, Germany    
  More Information

For List of Participants see http://www.cosbid.org/  This link exits the ClinicalTrials.gov site
 

Publications:

Study ID Numbers:   sor402605ctil
First Received:   November 22, 2005
Last Updated:   July 31, 2007
ClinicalTrials.gov Identifier:   NCT00258505
Health Authority:   Israel: Ministry of Health

Keywords provided by Soroka University Medical Center:
Spreading depression  
Seizures  
Blood-brain barrier  

Study placed in the following topic categories:
Craniocerebral Trauma
Cerebral Hemorrhage
Depression
Cerebral Infarction
Seizures
Stroke
Vascular Diseases
Wounds and Injuries
Disorders of Environmental Origin
Central Nervous System Diseases
Trauma, Nervous System
Ischemia
Intracranial Hemorrhages
Brain Diseases
Hemorrhage
Depressive Disorder
Cerebrovascular Disorders
Necrosis
Subarachnoid Hemorrhage
Brain Ischemia
Brain Infarction
Brain Injuries
Infarction

Additional relevant MeSH terms:
Pathologic Processes
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 04, 2008




Links to all studies - primarily for crawlers